NEWS & MEDIA

PR NEWSWIRE

PR NEWSWIRE

6 May 2020
PTC Therapeutics to Acquire Censa Pharmaceuticals

Read more

Business Wire

Business Wire

April 15 2020
UroGen Pharma Receives U.S. FDA Expedited Approval for Jelmyto™, the First and Only Non-Surgical Treatment for Patients with Low-Grade Upper Tract Urothelial Cancer

Read more

Fierce Biotech

Fierce Biotech

April 8 2020
Keros upsizes IPO, raising $96M for blood and musculoskeletal trials

Read more

Nasdaq

Nasdaq

April 7 2020
Hot blooded: Keros Therapeutics prices upsized IPO at $16, the high end of the range

Read more

Fierce Biotech

Fierce Biotech

25 March 2020
Redpin bags A round to advance Chantix-controlled gene therapies

Read more

Intrado GlobeNewswire

Intrado GlobeNewswire

11 March 2020
Biosight Raises $19M in Series C Funding to Support Clinical Stage Oncology Programs

Read more

Intrado GlobeNewswire

Intrado GlobeNewswire

11 March 2020
Biosight Raises $19M in Series C Funding to Support Clinical Stage Oncology Programs

Read more

Business Wire

Business Wire

9 MARCH 2020
Arkin Holdings Raises $140 Million in Second Partnership Arkin Bio-Ventures II to Invest in Groundbreaking Pharma and Biotechnology Companies

Read more

CALCALIST

CALCALIST

3 FEBRUARY 2020
Arkin Bio Ventures adds migdal as anchor investor, bringing Arkin Holdings scope in BioMed to 1.4$ Billion

Read more

GLOBES

GLOBES

29 MAY 2019
Pi Therapeutics raises $19.7M for its new approach to curing cancer

Read more

CALCALIST

CALCALIST

2 MAY 2019
Edwardo Elstein sells 10% of Clal Insurance to Mori Arkin and Yakir Gabay

Read more

CISION PR NEWSWIRE

CISION PR NEWSWIRE

30 JULY 2018
BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia

Read more

GLOBES

GLOBES

12 MARCH 2018
Accelemd's Cogentix Medical aquired by Laborie for $242M

Read more

CISION PR NEWSWIRE

CISION PR NEWSWIRE

12 MARCH 2018
Cogentix Medical Enters Definitive Merger Agreement to be Acquired by Laborie Medical Technologies for a Purchase Price of $3.85 Per Share in Cash

Read more

NASDAQ GLOBE NEWSWIRE

NASDAQ GLOBE NEWSWIRE

05 FEBRUARY 2018
Sol-Gel Technologies Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read more

GLOBES

GLOBES

1 FEBRUARY 2018
Sol-Gel raises $75M

Read more

GLOBES

GLOBES

8 JANUARY 2018
Ladenburg Thalmann Financial Services initiated coverage on shares of Urogen Pharma

Read more

NASDAQ GLOBE NEWSWIRE

NASDAQ GLOBE NEWSWIRE

5 JANUARY 2018
Retrophin and Censa Pharmaceuticals Enter into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU)

Read more

CALCALIST

CALCALIST

05 JANUARY 2018
Arkin Bioventures' Censa Pharmaceuticals raised $10M as part of a strategic long-term agreement with Retrophin

Read more

CALCALIST

CALCALIST

28 DECEMBER 2017
Merck, China’s WuXi AppTec and Mori Arkin to Launch Biotech Incubator in Israel

Read more

YAHOO FINANCE

YAHOO FINANCE

14 DECEMBER 2017
BioSight Announces Phase I/II Results of its Cytarabine Pro-Drug BST-236 for Treatment of Acute Leukemia

Read more

GLOBES

GLOBES

7 MAY 2017
Urogen,Israeli urological cancer treatment developer raised 20% more than planned in Nasdaq IPO

Read more

CALCALIST

CALCALIST

5 MAY 2017
Urogen Pharma rasise $58M in Nasdaq IPO

Read more

GLOBES

GLOBES

19 JUNE 2016
Arkin & Phoenix set up $60m biomed investment fund

Read more

PR NEWSWIRE

PR NEWSWIRE

16 MAY 2016
Arkin Holdings and Primera Capital Lead an Investment of $13M in BioSight for an Innovative Treatment of Acute Leukemia

Read more

THE PE HUB NETWORK

THE PE HUB NETWORK

12 APRIL 2016
Israel’s Metabomed raises $18 mln for cancer-metabolism drugs

Read more

FORBES

FORBES

4 JANUARY 2016
Mori Arkin personal history on Forbes 2015 billionaire rankings

Read more

GLOBES

GLOBES

3 JANUARY 2016
Israeli shareholder Arkin rejects Mylan Perrigo bid

Read more

EQUILAR ATLAS

EQUILAR ATLAS

15 SEPTEMBER 2015
Moshe Arkin, Former Board Member at PERRIGO, bibliography

Read more

REUTERS

REUTERS

10 SEPTEMBER 2015
Israeli Perrigo shareholder slams Mylan’s $27 billion offer

Read more

GLOBES

GLOBES

28 JULY 2015
Merck buys cCAM Biotherapeutics for up to $605m

Read more

BIOSPACE

BIOSPACE

1 JUNE 2015
cCAM Biotherapeutics receives FDA approval to initiate phase One trial for CM-24, a novel immune checkpoint inhibitor for cancer immunotherapy

Read more

GLOBES

GLOBES

17 JULY 2014
Mori Arkin in talks to buy Sol-Gel

Read more

JEWISH BUSINESS NEWS

JEWISH BUSINESS NEWS

14 JULY 2014
Perrigo up for sale

Read more

STREETINSIDER.COM

STREETINSIDER.COM

16 NOVEMBER 2011
Arkin Holdings lowers stake in Perrigo (PRGO) to 5.35%

Read more

PR NEWSWIRE

PR NEWSWIRE

13 SEPTEMBER 2007
Perrigo Vice Chair Mori Arkin To Retire After 30 Years of Service

Read more

FINANCIAL TIMES

FINANCIAL TIMES

15 NOVEMBER 2004
Perrigo buys Israel’s Agis for $818m

Read more